<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://chemwiki.ch.ic.ac.uk/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Hm206</id>
	<title>ChemWiki - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://chemwiki.ch.ic.ac.uk/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Hm206"/>
	<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/wiki/Special:Contributions/Hm206"/>
	<updated>2026-04-04T08:23:41Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14198</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14198"/>
		<updated>2007-12-07T17:47:27Z</updated>

		<summary type="html">&lt;p&gt;Hm206: deleted table&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14194</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14194"/>
		<updated>2007-12-07T17:44:40Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14187</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14187"/>
		<updated>2007-12-07T17:40:43Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&amp;lt;noinclude&amp;gt;&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14186</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14186"/>
		<updated>2007-12-07T17:40:18Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;noinclude&amp;gt;&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14185</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14185"/>
		<updated>2007-12-07T17:39:56Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14184</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14184"/>
		<updated>2007-12-07T17:39:33Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;noinclude&amp;gt;&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14183</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14183"/>
		<updated>2007-12-07T17:39:14Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14181</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14181"/>
		<updated>2007-12-07T17:38:51Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&amp;lt;noinclude&amp;gt;&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14180</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14180"/>
		<updated>2007-12-07T17:38:18Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;noinclude&amp;gt;&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14178</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14178"/>
		<updated>2007-12-07T17:37:36Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;noinclude&amp;gt;&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14174</id>
		<title>It07:Vitamin A</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Vitamin_A&amp;diff=14174"/>
		<updated>2007-12-07T17:36:07Z</updated>

		<summary type="html">&lt;p&gt;Hm206: contribution to article uploaded by someone else: jmol image, intro history, table with information and section on other forms&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Vitamin A or, in its most common form, retinol is, by virtue of its many functions in the human body, an important part of any balanced diet.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;vit&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;vit.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;noinclude&amp;gt;&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{PAGENAME}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:{{PAGENAME}}.jpg|200px|{{PAGENAME}}]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-1-ol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| retinol&lt;br /&gt;
  [7t,9t,11t,13t]-Retinol&lt;br /&gt;
  vitamin-A alcohol&lt;br /&gt;
  vitamin A&lt;br /&gt;
  axerophthol&lt;br /&gt;
  vitamin-A&lt;br /&gt;
  vitamin-A1&lt;br /&gt;
  vitamin-A1 alcohol&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C20H30O&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC(C)1C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 286.46&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| {{{CASNo}}}&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| 136 - 137 C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Structure&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Orbital_hybridisation Molecular shape] &amp;lt;!-- for simple covalent molecules (omit for most large molecules, ionics and complexes) --&amp;gt;&lt;br /&gt;
| {{{Mol_Shape}}} &amp;lt;!-- e.g. trigonal bipyramidal --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Coordination_geometry Coordination&amp;lt;br /&amp;gt;geometry] &amp;lt;!-- for a metal complex or an ionic crystal, otherwise omit --&amp;gt;&lt;br /&gt;
| {{{Coordination}}} &amp;lt;!-- e.g. trigonal bipyramidal --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Crystal_structure Crystal structure] &amp;lt;!-- omit if not a solid --&amp;gt;&lt;br /&gt;
| {{{Crystal_Structure}}} &amp;lt;!-- e.g. [[triclinic]], [[monoclinic]], [[orthorhombic]], [[hexagonal]], [[rhombohedral|trigonal]], [[tetragonal]], [[cubic]], and mention &amp;quot;close packed&amp;quot; or similar.  You may also cite what class it belongs to, e.g. [[Cadmium_chloride#Crystal_structure|CdCl&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;]]  --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [[Dipole#Molecular_dipoles|Dipole moment]]&lt;br /&gt;
| {{{DM}}} [[Debye|D]]&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Hazards &amp;lt;!--  Summary only- MSDS entry provides more complete information --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [[Material safety data sheet|MSDS]]&lt;br /&gt;
| [[{{PAGENAME}} (data page)#Material Safety Data Sheet|External MSDS]] &amp;lt;!-- please replace with proper link--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Main [[Worker safety and health|hazard]]s&lt;br /&gt;
| {{{Hazards}}} &amp;lt;!-- e.g. highly toxic, explosive, flammable, corrosive --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [[NFPA 704]]&lt;br /&gt;
| {{{NFPA}}}&amp;lt;!-- {{NFPA 704 | Health=4 | Flammability=4 | Reactivity=4 | Other=OX }} These are set on &amp;quot;very dangerous&amp;quot; as default- adjust according to actual values --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [[Flash point]]&lt;br /&gt;
| {{{Fp}}}°C&lt;br /&gt;
|-&lt;br /&gt;
| [[Risk and Safety Statements|R/S statement]]&lt;br /&gt;
| [[List of R-phrases|R]]: {{{R-S}}} &amp;lt;br /&amp;gt; [[List of S-phrases|S]]: ?&lt;br /&gt;
|-&lt;br /&gt;
| [[RTECS]] number&lt;br /&gt;
| {{{RTECS}}}&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | [[{{PAGENAME}} (data page)|Supplementary data page]]&lt;br /&gt;
|-&lt;br /&gt;
| [[{{PAGENAME}} (data page)#Structure and properties|Structure and&amp;lt;br /&amp;gt;properties]] &lt;br /&gt;
| [http://en.wikipedia.org/wiki/Refractive_index &#039;&#039;n&#039;&#039;], [http://en.wikipedia.org/wiki/Dielectric_constant ε&amp;lt;sub&amp;gt;r&amp;lt;/sub&amp;gt;], etc. &lt;br /&gt;
|-&lt;br /&gt;
| [[{{PAGENAME}} (data page)#Thermodynamic properties|Thermodynamic&amp;lt;br /&amp;gt;data]] &lt;br /&gt;
| Phase behaviour&amp;lt;br /&amp;gt;Solid, liquid, gas &lt;br /&gt;
|-&lt;br /&gt;
| [[{{PAGENAME}} (data page)#Spectral data|Spectral data]]&lt;br /&gt;
| [[UV/VIS spectroscopy|UV]], [[Infrared spectroscopy|IR]], [[nuclear magnetic resonance spectroscopy|NMR]], [[Mass spectrometry|MS]]&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Related compounds&lt;br /&gt;
|-&lt;br /&gt;
| Other [[Ion|anion]]s &amp;lt;!-- please omit if not applicable --&amp;gt;&lt;br /&gt;
| {{{Other_anion}}} &amp;lt;!-- Put in related anions e.g, iron(II) fluoride &amp;amp; iron(II) bromide if compound is iron(II) chloride --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Other [[Ion|cation]]s &amp;lt;!-- please omit if not applicable --&amp;gt;&lt;br /&gt;
| {{{Ohter_cation}}} &amp;lt;!-- Put in other oxidation states of same element e.g. [[iron(III) chloride]], also for related metals such as [[manganese(II) chloride]], [[cobalt(II) chloride]], ruthenium(III) chloride--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Related compounds &lt;br /&gt;
&amp;lt;!-- A miscellaneous heading - use for covalent inorganics;  e.g. for PCl&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; you would list PCl&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;, POCl&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;, PF&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;, PBr&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;, NCl&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; and AsCl&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;. &lt;br /&gt;
Please omit if not applicable --&amp;gt;&lt;br /&gt;
| {{{Relative_Compounds}}}&lt;br /&gt;
|-&lt;br /&gt;
| {{chembox header}} | &amp;lt;small&amp;gt;Except where noted otherwise, data are given for&amp;lt;br /&amp;gt; materials in their [[standard state|standard state (at 25&amp;amp;nbsp;°C, 100&amp;amp;nbsp;kPa)]]&amp;lt;br /&amp;gt;[[wikipedia:Chemical infobox|Infobox disclaimer and references]]&amp;lt;/small&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
{{Chem-Data_Structure}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
In 1906 it was being discovered that there were particular factors of food that were essential it to health.  Between 1912 and 1914 vitamin A itself was discovered by Elmer V. Mccollum and M. Davis and in 1913, Thomas Osborne and Lafayette Mendel discovered, in butter, a nutrient, now known as vitamin A, that is fat soluble. The first synthesis of vitamin A was in 1947.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Other Forms&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Vitamin A is found in forms other than its most common alcohol form, retinol. It is also found in an aldehyde form, retinal, and in a carboxylic acid form, retinoic acid.&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14170</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14170"/>
		<updated>2007-12-07T17:32:59Z</updated>

		<summary type="html">&lt;p&gt;Hm206: /* &amp;#039;&amp;#039;&amp;#039;Side Effects&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;25&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;38&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white solid&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain. As is the case with many drugs, the only way to tell which, if any, of the side effects will be developed in an individual is to actually take the drug.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|centre|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;SO&amp;lt;sub&amp;gt;4&amp;lt;/sub&amp;gt; that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14167</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14167"/>
		<updated>2007-12-07T17:28:34Z</updated>

		<summary type="html">&lt;p&gt;Hm206: /* &amp;#039;&amp;#039;&amp;#039;Synthesis&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;25&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;38&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white solid&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|centre|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;SO&amp;lt;sub&amp;gt;4&amp;lt;/sub&amp;gt; that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14164</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14164"/>
		<updated>2007-12-07T17:27:57Z</updated>

		<summary type="html">&lt;p&gt;Hm206: /* &amp;#039;&amp;#039;&amp;#039;Synthesis&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;25&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;38&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white solid&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|centre|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14162</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14162"/>
		<updated>2007-12-07T17:27:12Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;25&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;38&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white solid&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|centre|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14161</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=14161"/>
		<updated>2007-12-07T17:26:40Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;25&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;38&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white solid&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|left|180|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13705</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13705"/>
		<updated>2007-12-06T22:58:08Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;25&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;38&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white solid&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|left|180|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13703</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13703"/>
		<updated>2007-12-06T22:57:05Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C25H38O5&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white solid&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|left|180|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13702</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13702"/>
		<updated>2007-12-06T22:56:27Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Colemin, Lipex, Pantok, Synvinolin&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C25H38O5&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{white solid}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|left|180|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13701</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13701"/>
		<updated>2007-12-06T22:53:04Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Atenol, Altol, Corotenol, Tenolol, Xaten&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;22&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white powder&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-68-7&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13700</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13700"/>
		<updated>2007-12-06T22:50:52Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Atenol, Altol, Corotenol, Tenolol, Xaten&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;22&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| white powder&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-68-7&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13699</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13699"/>
		<updated>2007-12-06T22:48:28Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Atenol, Altol, Corotenol, Tenolol, Xaten&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;22&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-68-7&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13698</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13698"/>
		<updated>2007-12-06T22:47:58Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| Atenol,Altol,Corotenol, Tenolol, Xaten&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;22&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-68-7&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13697</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13697"/>
		<updated>2007-12-06T22:47:31Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| {{{Atenol,Altol,Corotenol, Tenolol, Xaten}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;22&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-68-7&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13696</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13696"/>
		<updated>2007-12-06T22:44:23Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| {{{OtherNames}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;22&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-68-7&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13695</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13695"/>
		<updated>2007-12-06T22:42:03Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| {{{OtherNames}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;22&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-86-7&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13694</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13694"/>
		<updated>2007-12-06T22:39:30Z</updated>

		<summary type="html">&lt;p&gt;Hm206: changed size of synthesis image&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| {{{OtherNames}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C25H38O5&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{white solid}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|left|180|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/jms.299 }}&amp;lt;/ref&amp;gt;A Mass spectrum of Simvastatin&lt;br /&gt;
[[Image:Simvastatin_mass_spec.GIF|center|200|A mass spectrum of Simvastatin]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13693</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13693"/>
		<updated>2007-12-06T22:37:20Z</updated>

		<summary type="html">&lt;p&gt;Hm206: added side effects section&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| {{{OtherNames}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C25H38O5&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{white solid}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Side Effects&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;Simvastatin Side Effects: An Introduction[http://drugs.emedtv.com/simvastatin/simvastatin-side-effects.html]&amp;lt;/ref&amp;gt; As with any drug, simvastatin also has side effects. Some common side effects include diarrhea, abdominal pain and indigestion and some of the less common side effects include memory loss, muscle cramps and joint pain.&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|left|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/jms.299 }}&amp;lt;/ref&amp;gt;A Mass spectrum of Simvastatin&lt;br /&gt;
[[Image:Simvastatin_mass_spec.GIF|center|200|A mass spectrum of Simvastatin]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13689</id>
		<title>It07:Simvastatin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Simvastatin&amp;diff=13689"/>
		<updated>2007-12-06T22:27:35Z</updated>

		<summary type="html">&lt;p&gt;Hm206: /* Simvastatin*/ uploaded full article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Simvastatin belongs to a group of drugs that inhibit the rate limiting enzyme of cholesterol synthesis in the body HMG-CoA reductase. It is especially useful in treating hypercholesterolemia a name given to a condition that is associated with high levels of cholesterol, in particular LDLs, in the blood.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{simvastatin}}&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:Simvastatin.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2,2-dimethyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| {{{OtherNames}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C25H38O5&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| O[C@@H]1C[C@@H](CC[C@@H]2[C@]3([H])C(C=C[C@@H]2C)=C[C@H](C)C[C@@H]3OC([C@](C)(C)CC)=O)OC(C1)=O&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 418.57&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{white solid}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 79902-63-9&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;3d Structure&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Sim.PDB&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;p132 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development... By Takuji Hara [http://books.google.com/books?id=8T7BD3eKT28C&amp;amp;pg=PA132&amp;amp;lpg=PA132&amp;amp;dq=simvastatin+history+discovery+merck+1979&amp;amp;source=web&amp;amp;ots=XyWvKfb23E&amp;amp;sig=QYTTnPk9tWXF2l4HZxtlqEOJMy4#PPA132,M1]&amp;lt;/ref&amp;gt; &lt;br /&gt;
The first HMG-CoA reductase inhibitor was discovered in 1973 by Akira Endo in Japan and was named mevastatin. Simvastatin is an analogue of this compound, and was chemically synthesised from lovastatin, another analogue of mevastatin, and launched in 1988 by Merck Co. in the US.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
 &lt;br /&gt;
&amp;lt;ref&amp;gt;http://www.medicinenet.com/simvastatin/article.htm &amp;lt;/ref&amp;gt;Simvastatin lowers cholesterol in the body by inhibiting its production in the liver. In addition to lowering overall cholesterol, it targets in particular coronary heart disease causing LDLs (low density lipoprotein).  Therefore the main use for Simvastatin is for treatment of high blood cholesterol as a secondary treatment to exercise, weight loss and a low cholesterol diet. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/hlca.200390066}}&amp;lt;/ref&amp;gt;Simvastatin can be safely and reliably synthesised from another compound that is also a statin, known as lovastatin. Although the starting reactant is the same as the final product apart from an extra methyl group, successful methylation of only that carbon and not the lactone C=O group(on the ring) depends on the introduction of a C=O protecting group. This, in addition to the introduction of an OH protecting group as well as the removal of these groups, accounts for the steps that are extra to the methylation of the side chain. &lt;br /&gt;
&lt;br /&gt;
In the first step lovastatin is treated with RCl and pyridine in a CHCl2 solvent where R may be PhCOCl or t-BuCO. This gives compound 2 which, in THF solvent, then has added to it ethane-1,2-diol, (EtO)3CH and an amount of H2SO4 that is catalytic. This gives the third compound known as an orthoformate. In the third step, this compound is treated with BuLi, MeI, pyrrolidine and water leading to the methylation of its (S)-2-methylbutanoyloxy side chain. The final compound, simvastatin, is obtained by removal of the C=O protecting group, by means of treating with dilute HCl in THF solvent, restoring the carbonyl group that was originally in that position in the starting product.&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin synthesis.gif|left|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|J. Phys. Chem. A, 108 (18), 3955 -3964, 2004. 10.1021/jp0498163 S1089-5639(04)09816-0}}&amp;lt;/ref&amp;gt;A 13C NMR spectrum of Simvastatin&lt;br /&gt;
&lt;br /&gt;
[[Image:simvastatin nmr.GIF|center|200|A 13C NMR spectrum of Simvastatin]]&lt;br /&gt;
&amp;lt;ref&amp;gt;{{DOI|10.1002/jms.299 }}&amp;lt;/ref&amp;gt;A Mass spectrum of Simvastatin&lt;br /&gt;
[[Image:Simvastatin_mass_spec.GIF|center|200|A mass spectrum of Simvastatin]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It:projects&amp;diff=13688</id>
		<title>It:projects</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It:projects&amp;diff=13688"/>
		<updated>2007-12-06T22:26:49Z</updated>

		<summary type="html">&lt;p&gt;Hm206: /* Supplemental  Project Page */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__FORCETOC__&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;You MUST use the  Edit buttons on the right to edit this content.  Do NOT use the Edit button on the top of this page.&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Sandbox (Play-Pen) ==	&lt;br /&gt;
 &lt;br /&gt;
This is an area where you can play without worrying what you do. Enter it by pressing the [Edit] button &#039;&#039;&#039;on the right&#039;&#039;&#039; and &#039;&#039;&#039;not&#039;&#039;&#039; at the top. Go here for a [http://en.wikipedia.org/wiki/Wikipedia:Cheatsheet &#039;&#039;cheat sheet&#039;&#039;] summary of how to create a Wiki page.	 It&#039;s a free-for-all in here! Learn how to use a Wiki by coming here! PS This is how to do Greek:&amp;amp;alpha;, &amp;amp;beta; &amp;amp;Delta;, &amp;amp;delta;	 		 &lt;br /&gt;
Try copying/pasting some of the [http://www.ch.ic.ac.uk/local/it/lab1.html examples in the course work] into this page. See the effect by selecting &#039;&#039;&#039;Show Preview&#039;&#039;&#039;. Do not use &#039;&#039;&#039;Save Page&#039;&#039;&#039; so as to leave this area uncluttered for others.&lt;br /&gt;
----&lt;br /&gt;
{| summary=&amp;quot;CIT Project  Titles&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
|NEW: This demonstrates the use of  Jmol loading discrete molecule files (rather than having to paste them into the wiki page).  Upload the molecule file, and invoke it as shown here. Use it for eg loading large proteins etc.--[[User:Rzepa|Rzepa]] 16:07, 4 December 2006 (UTC) and --[[User:Rzepa|Rzepa]] 07:41, 16 October 2007 (BST) and  --[[User:Rzepa|Rzepa]] 15:56, 18 October 2007 (BST)&lt;br /&gt;
&lt;br /&gt;
If no rotatable molecule appears to the right there my be a problem in the browser cache - reload the page bypassing the cache using ctrl+F5. If this doesn&#039;t work check that  [http://www.java.com/en/download/help/testvm.xml Java] is correctly functioning on your system.&lt;br /&gt;
&lt;br /&gt;
===References ===&lt;br /&gt;
This shows how citations&amp;lt;ref&amp;gt;Example of adding a citation {{DOI|10.1021/ja9825332}}&amp;lt;/ref&amp;gt; can be added to &lt;br /&gt;
text&amp;lt;ref&amp;gt;adding a further citation {{DOI|10.1021/ja9825332}}&amp;lt;/ref&amp;gt; to produce a nice effect.&lt;br /&gt;
&lt;br /&gt;
===Multiple uses of the same footnote ===&lt;br /&gt;
&lt;br /&gt;
The code for citing multiple quotes from the same source can be found [http://www.mediawiki.org/wiki/Extension:Cite/Cite.php here]. This stops the same reference being stated multiple times at the bottom of the page when you try to reference more than one item from the same source.&lt;br /&gt;
&lt;br /&gt;
=== Collected citations appear below here ===&lt;br /&gt;
&amp;lt;references /&amp;gt;--[[User:Rzepa|Rzepa]] 15:18, 25 October 2007 (BST)&lt;br /&gt;
|&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
&amp;lt;title&amp;gt;Pentahelicene&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;yellow&amp;lt;/color&amp;gt;&amp;lt;size&amp;gt;200&amp;lt;/size&amp;gt;&lt;br /&gt;
&amp;lt;script&amp;gt;zoom 80; cpk on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;uploadedFileContents&amp;gt;Pentahelicene.mol&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
&amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
&amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
&amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
&amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
&amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
&amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmol&amp;gt;&amp;lt;jmolAppletButton&amp;gt;&amp;lt;title&amp;gt;Show CIYSIM.cif in popup window&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;cyan&amp;lt;/color&amp;gt;&lt;br /&gt;
&amp;lt;uploadedFileContents&amp;gt;CIYSIM.cif&amp;lt;/uploadedFileContents&amp;gt;&amp;lt;/jmolAppletButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Main Project Page ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;URGENT Announcement&#039;&#039;&#039;&#039;&#039;  &lt;br /&gt;
&lt;br /&gt;
Whilst the  Wiki itself is pretty robust, and although it is difficult to break a page on it, this did happen a few days ago to project 12.  What seems to have happened is that some  &#039;&#039;bad&#039;&#039; code (HTML or XML) was copied from another Web page, and pasted into the  project 12 page.  The Wiki system could not cope with this particular bad code, and sulked.  Fortunately, by invoking appropriate magic, the page has now been restored to its state prior to the breakage, and  I have learnt a valuable lesson in how to fix it if this happens again. So this serves as a warning;  if you are copying/pasting blind from other web pages (which in general you should not be doing), you do run the risk of breaking the page.  Hopefully, the break will be detected during the preview, and serves to remind that you should  &#039;&#039;always&#039;&#039; preview before saving to detect any such breaks. --[[User:Rzepa|Rzepa]] 10:21, 28 November 2007 (UTC)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Please do not edit this page itself&#039;&#039;&#039;.  Click on one of the titles to start editing.&lt;br /&gt;
{| summary=&amp;quot;CIT Project  Titles&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
! bgcolor=&amp;quot;cyan&amp;quot; |Project&amp;lt;br /&amp;gt; Number&lt;br /&gt;
! bgcolor=&amp;quot;cyan&amp;quot; |General Keywords&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |01&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Lignocaine|Lignocaine (used in dentistry as a &amp;quot;local&amp;quot;)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |02&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Piperine|Piperine (active ingredient of both black and white pepper)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |03&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Rapamycin|Rapamycin (prevents transplant rejection)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |04&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Gossypol|Gossypol (male birth control)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |05&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Gentamycin|Gentamicin A (aminoglycoside antibiotic)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |06&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Herceptin|Herceptin (topical anticancer drug)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |07&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Gingerone|Zingerone (the characteristic smell of ginger)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |08&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Sucralose|Sucralose (non-metabolizable sweetening agent)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |09&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Bufotoxin|Bufotoxin (active component of the toad &#039;&#039;Bufo vulgaris&#039;&#039;)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |10&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Roaccutane|Roaccutane (treatment for severe acne)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |11&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Sibutramine|Sibutramine (appetite suppresor)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |12&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07a:Anandamide|Anandamide (the &amp;quot;feel-good&amp;quot; factor in chocolate)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |13&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:h3nbh3|Ammonia-borane: H&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;N-BH&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; (Hydrogen storage molecule?)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |14&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Methoxsalen|Methoxsalen (Treatment of psoriasis)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |15&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Hycocine|Hyoscine (From Mandrake and Witches Henbane, pre-med before surgery)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |16&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Capreomycin|Capreomycin (Drug-resistant TB)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |17	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:wilkinson|Wilkinson&#039;s catalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |18	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Jacobsen|Jacobsen&#039;s epoxidation catalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |19	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Methylaluminoxane|Methylaluminoxane: MAO - hugely important ethylene polymerisation cocatalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |20	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Schwartz|Schwartz reagent for the hydrozirconation of alkenes and alkynes]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |21	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Schrock|Schrock metathesis catalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |22	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:knots|Molecular-scale knots (nanoscale devices)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
|bgcolor=&amp;quot;#CCFF00&amp;quot; |23	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Vioxx|Vioxx (treatment of osteoarthritis symptoms and pain)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |24	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Sertraline|Sertraline HCl (anti-depression)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |25	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Ceftriaxone|Ceftriaxone (Gonorrhoea)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |26	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[i07t:Zithromycin|Zithromycin (anti-infective)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |27	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Lipitor|Lipitor (Cholesterol reducing agent)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |28	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Cyameluric Acid|Cyameluric acid (Linus Pauling&#039;s last idea!)]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Supplemental  Project Page ==&lt;br /&gt;
&lt;br /&gt;
This area is for people who wish to create their own projects if none of the above appeal to them. Click on the  &#039;&#039;&#039;Edit&#039;&#039;&#039;  button to the right to open up an editable page,&lt;br /&gt;
then add an entry below as follows&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;nowiki&amp;gt; [[it07:name_of_project|Descriptive name of intended project]]&amp;lt;/nowiki&amp;gt;&lt;br /&gt;
*This will produce the effect:  [[it07:name_of_project|Descriptive name of intended project]]&lt;br /&gt;
----&lt;br /&gt;
#[[it07:sitagliptin_page|An example entry- in edit mode, please copy this line and paste below to add to this list]]&lt;br /&gt;
#[[it07:Limonene|Limonene]]&lt;br /&gt;
#[[it07:name_of_project|Vitamin C ]]&lt;br /&gt;
#[[it07:Cylcophosphamide|Cyclophosphamide]]&lt;br /&gt;
#[[it07:Terbutaline Sulphate|Terbutaline Sulphate]]&lt;br /&gt;
#[[it07:Caffeine|Caffeine]]&lt;br /&gt;
#[[it07:Mefloquine|Mefloquine]]&lt;br /&gt;
#[[it07:Cadaverine|Cadaverine]]&lt;br /&gt;
#[[it07:Cyanidin|Cyanidin]]&lt;br /&gt;
#[[it07:Ezetimibe|Ezetimibe]]&lt;br /&gt;
#[[it07:Octanitrocubane|Octanitrocubane]]&lt;br /&gt;
#[[it07:Azadirachtin|Azadirachtin]]&lt;br /&gt;
#[[it07:Nicotine|Nicotine]]&lt;br /&gt;
#[[it07:Cyclopentasiloxane|Cyclopentasiloxane]]&lt;br /&gt;
#[[it07:Trinitrotoluene|Trinitrotoluene]]&lt;br /&gt;
#[[it07:Hydroxychloroquine|Hydroxychloroquine]]&lt;br /&gt;
#[[it07:Aspartame|Aspartame]]&lt;br /&gt;
#[[it07:Azulene|Azulene]]&lt;br /&gt;
#[[it07:Chlorine Trifluoride|Chlorine Trifluoride]]&lt;br /&gt;
#[[it07:Cholesterol|Cholesterol]]&lt;br /&gt;
#[[it07:Vitamin E|Vitamin E]]&lt;br /&gt;
#[[it07:Phenothiazine|Phenothiazine]]&lt;br /&gt;
#[[it07:linalool|linalool]]&lt;br /&gt;
#[[it07:Glutamic acid|Glutamic acid]]&lt;br /&gt;
#[[it07:N-(4-hydroxyphenyl)ethanamide|N-(4-hydroxyphenyl)ethanamide]]&lt;br /&gt;
#[[it07:Epinephrine|Epinephrine]]&lt;br /&gt;
#[[it07:Sodium Valproate|Sodium Valproate]]&lt;br /&gt;
#[[it07:Hyaluronic acid |Hyaluronic acid  ]]&lt;br /&gt;
#[[it07:Methylenedioxymethamphetamine |Methylenedioxymethamphetamine ]]&lt;br /&gt;
#[[it07:salicylic acid |salicylic acid ]]&lt;br /&gt;
#[[it07:Morphine|Morphine]]&lt;br /&gt;
#[[Cetirizine]]&lt;br /&gt;
#[[it07:Bisacodyl|Bisacodyl]]&lt;br /&gt;
#[[it07:Rivaroxaban|Rivaroxaban]]&lt;br /&gt;
#[[it07:Sodium Lauryl Sulfate|Sodium Lauryl Sulfate]]&lt;br /&gt;
#[[it07:Silicon Dioxide|Silicon Dioxide]]&lt;br /&gt;
#[[it07:Vanillin|Vanillin]]&lt;br /&gt;
#[[it07:Tetrahydrocannabinol|Tetrahydrocannabinol]]&lt;br /&gt;
#[[it07:Capsaicin|Capsaicin]]&lt;br /&gt;
#[[it07:Menthol|Menthol]]&lt;br /&gt;
#[[it07:Tamoxifen|Tamoxifen]]&lt;br /&gt;
#[[it07:Copper arsenate|Scheele&#039;s Green]]&lt;br /&gt;
#[[it07:Strychnine|Strychnine]]&lt;br /&gt;
#[[it07:Testosterone|Testosterone]]&lt;br /&gt;
#[[it07:Monosodium glutamate|Monosodium glutamate]]&lt;br /&gt;
#[[it07:Taurine|Taurine]]&lt;br /&gt;
#[[it07:Phenethylamine|Phenethylamine]]&lt;br /&gt;
#[[it07:Verbenone|Verbenone]]&lt;br /&gt;
#[[it07:Salbutamol|Salbutamol]]&lt;br /&gt;
#[[it07:Lactic acid|Lactic acid]]&lt;br /&gt;
#[[it07:Aspirin|Aspirin]]&lt;br /&gt;
#[[it07:EDTA|EDTA]]&lt;br /&gt;
#[[it07:Heroin|Heroin]]&lt;br /&gt;
#[[it07:Cocaine|Cocaine]]&lt;br /&gt;
#[[it07:Myristicin|Myristin (The hallucinogen in nutmeg)]]&lt;br /&gt;
#[[it07:Encefabol|Encefabol]]&lt;br /&gt;
#[[it07:Sarin|Sarin]]&lt;br /&gt;
#[[Thebaine]]&lt;br /&gt;
#[[Nitroglycerin]]&lt;br /&gt;
#[[it07:Methamphetamine|Methamphetamine]]&lt;br /&gt;
#[[it07:Sildenafil|Sildenafil]]&lt;br /&gt;
#[[Grubbs&#039; Catalyst]]&lt;br /&gt;
#[[it07:Warfarin|Warfarin]]&lt;br /&gt;
#[[it07:Angelic Acid|Angelic Acid]]&lt;br /&gt;
#[[it07:Melem (Melon) |Melem]]&lt;br /&gt;
#[[it07:oxazaborolidines|Chiral Oxazaborolidines as Catalysts]]&lt;br /&gt;
#[[it07:RDX|RDX (chemical in plastic explosives)]]&lt;br /&gt;
#[[it07:Lysergic Acid|Lysergic Acid]]&lt;br /&gt;
#[[it07:Oseltamivir Phosphate|Oseltamivir Phosphate(Tamiflu)]]&lt;br /&gt;
#[[Fluoxetine Hydrochloride (Prozac)]]&lt;br /&gt;
#[[Dimethylmercury]]&lt;br /&gt;
#[[it07:Sorafenib(Nexavar®)|Sorafenib (Nexavar®)]]&lt;br /&gt;
#[[Rapamycin]]&lt;br /&gt;
#[[Rohypnol]]&lt;br /&gt;
#[[it07:Vitamin A|Vitamin A (Retinol)]]&lt;br /&gt;
#[[it07:THC|Tetrahydrocannabinol]]&lt;br /&gt;
#[[2,4-Dinitrophenylhydrazine|2,4-Dinitrophenylhydrazine]]&lt;br /&gt;
#[[Acetylcholine]]&lt;br /&gt;
#[[it07:Phenolphthalein|Phenolphthalein]]&lt;br /&gt;
#[[Carbon Dioxide]]&lt;br /&gt;
#[[Domoic Acid]]&lt;br /&gt;
#[[Kevlar]]&lt;br /&gt;
#[[it07:Erythromycin|Erythromycin]]&lt;br /&gt;
#[[it07:DIBAL|DIBAL]]&lt;br /&gt;
#[[Ephedrine]]&lt;br /&gt;
#[[it07:Lactose|Lactose]]&lt;br /&gt;
#[[it07:Thyjone|Thyjone]]&lt;br /&gt;
#[[Levothyroxine]]&lt;br /&gt;
#[[it07:Tropinone|Tropinone]]&lt;br /&gt;
#[[it07:Ozone|Ozone]]&lt;br /&gt;
#[[it07:Indinavir|Indinavir (Crixivan®)]]&lt;br /&gt;
#[[it07:Tetrodotoxin|Tetrodotoxin]]&lt;br /&gt;
#[[it07:Astaxanthin|Astaxanthin]]&lt;br /&gt;
#[[Methane]]&lt;br /&gt;
#[[it07:2 – Chlorobenzalmalononitrile|2 – Chlorobenzalmalononitrile (CS Gas)]]&lt;br /&gt;
#[[it07:Dichloro-Diphenyl-Trichloroethane|Dichloro-Diphenyl-Trichloroethane]]&lt;br /&gt;
#[[it07:Ketamine|Ketamine]]&lt;br /&gt;
#[[it07:Ethylene Glycol|Ethylene Glycol]]&lt;br /&gt;
#[[it07:HMX|HMX]]&lt;br /&gt;
#[[it07:Psilocybin|Psilocybin (magic mushrooms)]]&lt;br /&gt;
#[[it07:Dopamine|Dopamine]]&lt;br /&gt;
#[[it07:Mefenamic Acid|Mefenamic Acid]]&lt;br /&gt;
#[[it07:Sesamin|Sesamin]]&lt;br /&gt;
#[[it07:Riboflavin|Riboflavin (Vitamin B2)]]&lt;br /&gt;
#[[it07:Coniine|Coniine]]&lt;br /&gt;
#[[it07:Capecitabine|Capecitabine]]&lt;br /&gt;
#[[it07:Atenolol|Atenolol]]&lt;br /&gt;
#[[it07:Simvastatin|Simvastatin]]&lt;br /&gt;
&lt;br /&gt;
== Wiki Templates ==&lt;br /&gt;
&lt;br /&gt;
[[Template:DOI]] and [[Template:Doi-inline]] are providea as (protected) templates for your use. Many other templates exist, often to be found on e.g. Wikipedia pages. You may decide one of these is of particular use, or of interest. If so, you can install it on the wiki here for you and others to use. Add below a line that looks like Template:Template-name, save, and click on the red text to create the new template. If you prefer the task of adding useful templates to that of adding information about molecules, then you will be given full credit for performing this valuable service for others! --Rzepa 14:41, 20 October 2006 (BST) &lt;br /&gt;
&lt;br /&gt;
[[Template:Chem-Data]]&lt;br /&gt;
&lt;br /&gt;
[[Template:Drug-Box]] - For pharmaceutical drugs just copy variable names and code generates tables&lt;br /&gt;
&lt;br /&gt;
[[Template:Chembox supplement]] - to be linked to from the supplementary section of the table in the template above, for usage see [[Template_talk:chembox_supplement|here]]&lt;br /&gt;
&lt;br /&gt;
[[Template:NFPA_704]] - for notes on how to use, see [[Template_talk:NFPA_704|here]]&lt;br /&gt;
&lt;br /&gt;
[[R &amp;amp; S Phrases]]&lt;br /&gt;
&lt;br /&gt;
[[Template:Chembox new]]&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13687</id>
		<title>It07:Atenolol</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Atenolol&amp;diff=13687"/>
		<updated>2007-12-06T22:25:37Z</updated>

		<summary type="html">&lt;p&gt;Hm206: /* Atenolol*/ uploaded full article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;http://www.medicinenet.com/atenolol/article.htm &amp;lt;/ref&amp;gt;Atenolol is a beta blocking compound and is used to block the involuntary part of the nervous system known as the sympathetic nervous system. As this part of the nervous system is responsible for the stimulation of the heart beat, its suppression by blocking the action of the respective nerves causes a reduction in heart rate. In contrast to many beta blockers, atenolol is β1 selective and therefore blocks receptors corresponding to heart activity specifically. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- This template has been defined after elaborate discussion in the Chemicals Wikiproject. Please do not add, deleted or otherwise change it unless after due discussion in [[wikipedia talk:WikiProject Chemicals]] --&amp;gt;&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;{| class=&amp;quot;toccolours&amp;quot; border=&amp;quot;1&amp;quot; style=&amp;quot;float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse; width: 280px&amp;quot;&lt;br /&gt;
! {{chembox header}} | {{atenolol}} &amp;lt;!-- replace if not identical with the article name --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| align=&amp;quot;center&amp;quot; colspan=&amp;quot;2&amp;quot; bgcolor=&amp;quot;#ffffff&amp;quot; | [[Image:atenolol.gif|right|200|up|500|]] &amp;lt;!-- replace if not identical with the pagename --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | General&lt;br /&gt;
|- &lt;br /&gt;
| [http://en.wikipedia.org/wiki/IUPAC Systematic name]&lt;br /&gt;
| 2-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Other names&lt;br /&gt;
| {{{OtherNames}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_formula Molecular formula]&lt;br /&gt;
| C14H22N2O3&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Chemical_file_format SMILES] &amp;lt;!-- mostly for organic compounds, omit otherwise --&amp;gt;&lt;br /&gt;
| CC(NCC(O)COC1=CC=C(CC(N)=O)C=C1)C&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Molar_mass Molar mass]&lt;br /&gt;
| 266.34&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Appearance&lt;br /&gt;
| {{{Appearance}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/CAS_registry_number CAS number]&lt;br /&gt;
| 29122-86-7&lt;br /&gt;
|-&lt;br /&gt;
! {{chembox header}} | Properties&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Density Density] &amp;amp; [http://en.wikipedia.org/wiki/Phase_%28matter%29 phase]&lt;br /&gt;
| {{{Density}}} g/cm³ &amp;lt;!-- ? g/cm³, solid / ? g/ml, liquid / ? g/l, gas --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Solubility Solubility in water]&lt;br /&gt;
| {{{Sol_Water}}} g/100 ml (25°C) &amp;lt;!--  at least put miscible with, not soluble in --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&amp;lt;!-- | Other solvents e.g. [[ethanol]], [[acetone]] --&amp;gt;&lt;br /&gt;
&amp;lt;!-- | solubility info on other solvents --&amp;gt;&lt;br /&gt;
&amp;lt;!-- |- --&amp;gt;&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Melting_point Melting point]&lt;br /&gt;
| {{{Mp}}} K &amp;lt;!-- (mention any decomposition) --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Boiling_point Boiling point]&lt;br /&gt;
| {{{Bp}}} K&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Acidity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not an acid or a base.  If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKa}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Acid_dissociation_constant Basicity] (p&#039;&#039;K&#039;&#039;&amp;lt;sub&amp;gt;b&amp;lt;/sub&amp;gt;) &amp;lt;!-- omit if not a base. If several values, be clear --&amp;gt;&lt;br /&gt;
| {{{pKb}}}&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Specific_rotation Chiral rotation &amp;lt;nowiki&amp;gt;[α]&amp;lt;/nowiki&amp;gt;&amp;lt;sub&amp;gt;D&amp;lt;/sub&amp;gt;] &amp;lt;!-- (Only include this for chiral compounds, indicate direction/enantiomer combo if known) --&amp;gt;&lt;br /&gt;
| {{{Rotation}}}°&lt;br /&gt;
|-&lt;br /&gt;
| [http://en.wikipedia.org/wiki/Viscosity Viscosity]&lt;br /&gt;
| {{{Viscosity}}} [[Poise|cP]] at 25°C &amp;lt;!-- Liquids only, omit if data unavailable. You may use [[Pascal second|Pa.s]] if you prefer --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3d structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;atenolol&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;dots on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Atenolol.MOL&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;History&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol information page [http://www.beezya.com/pages/atenolol.html]  &amp;lt;/ref&amp;gt;Atenolol was intended to replace another β blocker known as propranolol to treat hypertension and was introduced in 1976. Whilst sharing a common β blocking property with propranol, it had the advantage of not being able to get through the blood brain barrier a flaw intrinsic of propranol that resulted in side effects such as nightmares. More recently in 2006, Atenolol was downgraded from first to fourth line of treatment following evidence of its inferior performance to other drugs, more &lt;br /&gt;
significantly when treating elderly patients. It is still however, the most widely used β blocker in the UK.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Many of the applications of atenolol are, due to its effect of reducing heart rate and force of heart contractions, related to coronary afflictions. These include the treatment of high blood pressure, or hypertension, chest pains, or angina pectoris, and the reduction unusually quick heart rates. Its treatment of angina is a consequence of the causing of reduced demand for oxygen from the heart, as a result of the lower demands from the cardiac muscle, in response to the hearts oxygen demand exceeding its supply as caused by angina.   &lt;br /&gt;
== &#039;&#039;&#039;Side effects&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Atenolol Side Effects [http://blood-pressure.emedtv.com/atenolol/atenolol-side-effects.html] &amp;lt;/ref&amp;gt;There are numerous side effects that result from atenolol; some are more common and less serious and others occur more rarely but are more severe. Some of the more common side effects include depression, tiredness dizziness and shortness of breath. More scarcely occurring side effects are allergic reactions, vision problems and reversible hair loss. Some of the most serious side effects that could be caused are irregular heartbeat, difficulty in breathing or swallowing and chest pain. Prior to taking the drug there is no way to know which, if any, of the side effects will be developed in any one person therefore it is at the individuals’ discretion to report anything unusual to their medical practitioner.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Synthesis&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Due to the chiral centre (on the carbon that has the hydroxyl group attached), there are two possible optical isomers of Atenolol.  &amp;lt;ref&amp;gt; {{DOI|10.1080/00397919908085905}} &amp;lt;/ref&amp;gt; The desirable β-blocking property is associated with the (S) enantiomer and it is speculated that the (R) enantiomer is responsible for the side effects. Consequently syntheses that result in the pure (S) enantiomer have been developed. &amp;lt;ref&amp;gt;CsF in organic synthesis. Regioselective nucleophilic reactions of phenols with oxiranes leading to enantiopure β-blockers [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6THR-3YF46BF-F&amp;amp;_user=217827&amp;amp;_coverDate=12%2F10%2F1999&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000011279&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=217827&amp;amp;md5=2fcfe98486503ce83d7ba364bd8b5195]&amp;lt;/ref&amp;gt;One such synthesis is as follows :&lt;br /&gt;
&lt;br /&gt;
[[Image:atenolol synthesis.gif|center|200|Description of image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Spectroscopy and Spectrometry&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
[[Image:Atenolol IR.GIF|center|200|Infra-red spectrum of Atenolol]]&lt;br /&gt;
                              &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Infra-red Spectrum of Atenolol&lt;br /&gt;
[[Image:Atenolol_mass_spec.GIF |center|200|Mass Spectrum of Atenolol]]&lt;br /&gt;
                                  &amp;lt;ref&amp;gt;Integrated Spectral Database System of Organic Compounds (Data were obtained from the National Institute of Advanced Industrial Science and Technology (Japan)) &amp;lt;/ref&amp;gt;Mass Spectrum of Atenolol&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It:projects&amp;diff=13686</id>
		<title>It:projects</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It:projects&amp;diff=13686"/>
		<updated>2007-12-06T22:23:38Z</updated>

		<summary type="html">&lt;p&gt;Hm206: /* Supplemental  Project Page */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__FORCETOC__&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;You MUST use the  Edit buttons on the right to edit this content.  Do NOT use the Edit button on the top of this page.&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Sandbox (Play-Pen) ==	&lt;br /&gt;
 &lt;br /&gt;
This is an area where you can play without worrying what you do. Enter it by pressing the [Edit] button &#039;&#039;&#039;on the right&#039;&#039;&#039; and &#039;&#039;&#039;not&#039;&#039;&#039; at the top. Go here for a [http://en.wikipedia.org/wiki/Wikipedia:Cheatsheet &#039;&#039;cheat sheet&#039;&#039;] summary of how to create a Wiki page.	 It&#039;s a free-for-all in here! Learn how to use a Wiki by coming here! PS This is how to do Greek:&amp;amp;alpha;, &amp;amp;beta; &amp;amp;Delta;, &amp;amp;delta;	 		 &lt;br /&gt;
Try copying/pasting some of the [http://www.ch.ic.ac.uk/local/it/lab1.html examples in the course work] into this page. See the effect by selecting &#039;&#039;&#039;Show Preview&#039;&#039;&#039;. Do not use &#039;&#039;&#039;Save Page&#039;&#039;&#039; so as to leave this area uncluttered for others.&lt;br /&gt;
----&lt;br /&gt;
{| summary=&amp;quot;CIT Project  Titles&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
|NEW: This demonstrates the use of  Jmol loading discrete molecule files (rather than having to paste them into the wiki page).  Upload the molecule file, and invoke it as shown here. Use it for eg loading large proteins etc.--[[User:Rzepa|Rzepa]] 16:07, 4 December 2006 (UTC) and --[[User:Rzepa|Rzepa]] 07:41, 16 October 2007 (BST) and  --[[User:Rzepa|Rzepa]] 15:56, 18 October 2007 (BST)&lt;br /&gt;
&lt;br /&gt;
If no rotatable molecule appears to the right there my be a problem in the browser cache - reload the page bypassing the cache using ctrl+F5. If this doesn&#039;t work check that  [http://www.java.com/en/download/help/testvm.xml Java] is correctly functioning on your system.&lt;br /&gt;
&lt;br /&gt;
===References ===&lt;br /&gt;
This shows how citations&amp;lt;ref&amp;gt;Example of adding a citation {{DOI|10.1021/ja9825332}}&amp;lt;/ref&amp;gt; can be added to &lt;br /&gt;
text&amp;lt;ref&amp;gt;adding a further citation {{DOI|10.1021/ja9825332}}&amp;lt;/ref&amp;gt; to produce a nice effect.&lt;br /&gt;
&lt;br /&gt;
===Multiple uses of the same footnote ===&lt;br /&gt;
&lt;br /&gt;
The code for citing multiple quotes from the same source can be found [http://www.mediawiki.org/wiki/Extension:Cite/Cite.php here]. This stops the same reference being stated multiple times at the bottom of the page when you try to reference more than one item from the same source.&lt;br /&gt;
&lt;br /&gt;
=== Collected citations appear below here ===&lt;br /&gt;
&amp;lt;references /&amp;gt;--[[User:Rzepa|Rzepa]] 15:18, 25 October 2007 (BST)&lt;br /&gt;
|&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
&amp;lt;title&amp;gt;Pentahelicene&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;yellow&amp;lt;/color&amp;gt;&amp;lt;size&amp;gt;200&amp;lt;/size&amp;gt;&lt;br /&gt;
&amp;lt;script&amp;gt;zoom 80; cpk on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;uploadedFileContents&amp;gt;Pentahelicene.mol&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
&amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
&amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
&amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
&amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
&amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
&amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmol&amp;gt;&amp;lt;jmolAppletButton&amp;gt;&amp;lt;title&amp;gt;Show CIYSIM.cif in popup window&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;cyan&amp;lt;/color&amp;gt;&lt;br /&gt;
&amp;lt;uploadedFileContents&amp;gt;CIYSIM.cif&amp;lt;/uploadedFileContents&amp;gt;&amp;lt;/jmolAppletButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Main Project Page ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;URGENT Announcement&#039;&#039;&#039;&#039;&#039;  &lt;br /&gt;
&lt;br /&gt;
Whilst the  Wiki itself is pretty robust, and although it is difficult to break a page on it, this did happen a few days ago to project 12.  What seems to have happened is that some  &#039;&#039;bad&#039;&#039; code (HTML or XML) was copied from another Web page, and pasted into the  project 12 page.  The Wiki system could not cope with this particular bad code, and sulked.  Fortunately, by invoking appropriate magic, the page has now been restored to its state prior to the breakage, and  I have learnt a valuable lesson in how to fix it if this happens again. So this serves as a warning;  if you are copying/pasting blind from other web pages (which in general you should not be doing), you do run the risk of breaking the page.  Hopefully, the break will be detected during the preview, and serves to remind that you should  &#039;&#039;always&#039;&#039; preview before saving to detect any such breaks. --[[User:Rzepa|Rzepa]] 10:21, 28 November 2007 (UTC)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Please do not edit this page itself&#039;&#039;&#039;.  Click on one of the titles to start editing.&lt;br /&gt;
{| summary=&amp;quot;CIT Project  Titles&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
! bgcolor=&amp;quot;cyan&amp;quot; |Project&amp;lt;br /&amp;gt; Number&lt;br /&gt;
! bgcolor=&amp;quot;cyan&amp;quot; |General Keywords&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |01&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Lignocaine|Lignocaine (used in dentistry as a &amp;quot;local&amp;quot;)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |02&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Piperine|Piperine (active ingredient of both black and white pepper)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |03&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Rapamycin|Rapamycin (prevents transplant rejection)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |04&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Gossypol|Gossypol (male birth control)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |05&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Gentamycin|Gentamicin A (aminoglycoside antibiotic)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |06&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Herceptin|Herceptin (topical anticancer drug)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |07&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Gingerone|Zingerone (the characteristic smell of ginger)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |08&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Sucralose|Sucralose (non-metabolizable sweetening agent)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |09&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Bufotoxin|Bufotoxin (active component of the toad &#039;&#039;Bufo vulgaris&#039;&#039;)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |10&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Roaccutane|Roaccutane (treatment for severe acne)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |11&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Sibutramine|Sibutramine (appetite suppresor)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |12&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07a:Anandamide|Anandamide (the &amp;quot;feel-good&amp;quot; factor in chocolate)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |13&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:h3nbh3|Ammonia-borane: H&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;N-BH&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; (Hydrogen storage molecule?)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |14&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Methoxsalen|Methoxsalen (Treatment of psoriasis)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |15&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Hycocine|Hyoscine (From Mandrake and Witches Henbane, pre-med before surgery)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |16&lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Capreomycin|Capreomycin (Drug-resistant TB)]]&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |17	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:wilkinson|Wilkinson&#039;s catalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |18	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Jacobsen|Jacobsen&#039;s epoxidation catalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |19	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Methylaluminoxane|Methylaluminoxane: MAO - hugely important ethylene polymerisation cocatalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |20	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Schwartz|Schwartz reagent for the hydrozirconation of alkenes and alkynes]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |21	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Schrock|Schrock metathesis catalyst]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |22	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:knots|Molecular-scale knots (nanoscale devices)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
|bgcolor=&amp;quot;#CCFF00&amp;quot; |23	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Vioxx|Vioxx (treatment of osteoarthritis symptoms and pain)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |24	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Sertraline|Sertraline HCl (anti-depression)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |25	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Ceftriaxone|Ceftriaxone (Gonorrhoea)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |26	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[i07t:Zithromycin|Zithromycin (anti-infective)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |27	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; | [[it07:Lipitor|Lipitor (Cholesterol reducing agent)]]	 &lt;br /&gt;
|-	 &lt;br /&gt;
| bgcolor=&amp;quot;#CCFF00&amp;quot; |28	 &lt;br /&gt;
| bgcolor=&amp;quot;#66FF99&amp;quot; | [[it07:Cyameluric Acid|Cyameluric acid (Linus Pauling&#039;s last idea!)]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Supplemental  Project Page ==&lt;br /&gt;
&lt;br /&gt;
This area is for people who wish to create their own projects if none of the above appeal to them. Click on the  &#039;&#039;&#039;Edit&#039;&#039;&#039;  button to the right to open up an editable page,&lt;br /&gt;
then add an entry below as follows&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;nowiki&amp;gt; [[it07:name_of_project|Descriptive name of intended project]]&amp;lt;/nowiki&amp;gt;&lt;br /&gt;
*This will produce the effect:  [[it07:name_of_project|Descriptive name of intended project]]&lt;br /&gt;
----&lt;br /&gt;
#[[it07:sitagliptin_page|An example entry- in edit mode, please copy this line and paste below to add to this list]]&lt;br /&gt;
#[[it07:Limonene|Limonene]]&lt;br /&gt;
#[[it07:name_of_project|Vitamin C ]]&lt;br /&gt;
#[[it07:Cylcophosphamide|Cyclophosphamide]]&lt;br /&gt;
#[[it07:Terbutaline Sulphate|Terbutaline Sulphate]]&lt;br /&gt;
#[[it07:Caffeine|Caffeine]]&lt;br /&gt;
#[[it07:Mefloquine|Mefloquine]]&lt;br /&gt;
#[[it07:Cadaverine|Cadaverine]]&lt;br /&gt;
#[[it07:Cyanidin|Cyanidin]]&lt;br /&gt;
#[[it07:Ezetimibe|Ezetimibe]]&lt;br /&gt;
#[[it07:Octanitrocubane|Octanitrocubane]]&lt;br /&gt;
#[[it07:Azadirachtin|Azadirachtin]]&lt;br /&gt;
#[[it07:Nicotine|Nicotine]]&lt;br /&gt;
#[[it07:Cyclopentasiloxane|Cyclopentasiloxane]]&lt;br /&gt;
#[[it07:Trinitrotoluene|Trinitrotoluene]]&lt;br /&gt;
#[[it07:Hydroxychloroquine|Hydroxychloroquine]]&lt;br /&gt;
#[[it07:Aspartame|Aspartame]]&lt;br /&gt;
#[[it07:Azulene|Azulene]]&lt;br /&gt;
#[[it07:Chlorine Trifluoride|Chlorine Trifluoride]]&lt;br /&gt;
#[[it07:Cholesterol|Cholesterol]]&lt;br /&gt;
#[[it07:Vitamin E|Vitamin E]]&lt;br /&gt;
#[[it07:Phenothiazine|Phenothiazine]]&lt;br /&gt;
#[[it07:linalool|linalool]]&lt;br /&gt;
#[[it07:Glutamic acid|Glutamic acid]]&lt;br /&gt;
#[[it07:N-(4-hydroxyphenyl)ethanamide|N-(4-hydroxyphenyl)ethanamide]]&lt;br /&gt;
#[[it07:Epinephrine|Epinephrine]]&lt;br /&gt;
#[[it07:Sodium Valproate|Sodium Valproate]]&lt;br /&gt;
#[[it07:Hyaluronic acid |Hyaluronic acid  ]]&lt;br /&gt;
#[[it07:Methylenedioxymethamphetamine |Methylenedioxymethamphetamine ]]&lt;br /&gt;
#[[it07:salicylic acid |salicylic acid ]]&lt;br /&gt;
#[[it07:Morphine|Morphine]]&lt;br /&gt;
#[[Cetirizine]]&lt;br /&gt;
#[[it07:Bisacodyl|Bisacodyl]]&lt;br /&gt;
#[[it07:Rivaroxaban|Rivaroxaban]]&lt;br /&gt;
#[[it07:Sodium Lauryl Sulfate|Sodium Lauryl Sulfate]]&lt;br /&gt;
#[[it07:Silicon Dioxide|Silicon Dioxide]]&lt;br /&gt;
#[[it07:Vanillin|Vanillin]]&lt;br /&gt;
#[[it07:Tetrahydrocannabinol|Tetrahydrocannabinol]]&lt;br /&gt;
#[[it07:Capsaicin|Capsaicin]]&lt;br /&gt;
#[[it07:Menthol|Menthol]]&lt;br /&gt;
#[[it07:Tamoxifen|Tamoxifen]]&lt;br /&gt;
#[[it07:Copper arsenate|Scheele&#039;s Green]]&lt;br /&gt;
#[[it07:Strychnine|Strychnine]]&lt;br /&gt;
#[[it07:Testosterone|Testosterone]]&lt;br /&gt;
#[[it07:Monosodium glutamate|Monosodium glutamate]]&lt;br /&gt;
#[[it07:Taurine|Taurine]]&lt;br /&gt;
#[[it07:Phenethylamine|Phenethylamine]]&lt;br /&gt;
#[[it07:Verbenone|Verbenone]]&lt;br /&gt;
#[[it07:Salbutamol|Salbutamol]]&lt;br /&gt;
#[[it07:Lactic acid|Lactic acid]]&lt;br /&gt;
#[[it07:Aspirin|Aspirin]]&lt;br /&gt;
#[[it07:EDTA|EDTA]]&lt;br /&gt;
#[[it07:Heroin|Heroin]]&lt;br /&gt;
#[[it07:Cocaine|Cocaine]]&lt;br /&gt;
#[[it07:Myristicin|Myristin (The hallucinogen in nutmeg)]]&lt;br /&gt;
#[[it07:Encefabol|Encefabol]]&lt;br /&gt;
#[[it07:Sarin|Sarin]]&lt;br /&gt;
#[[Thebaine]]&lt;br /&gt;
#[[Nitroglycerin]]&lt;br /&gt;
#[[it07:Methamphetamine|Methamphetamine]]&lt;br /&gt;
#[[it07:Sildenafil|Sildenafil]]&lt;br /&gt;
#[[Grubbs&#039; Catalyst]]&lt;br /&gt;
#[[it07:Warfarin|Warfarin]]&lt;br /&gt;
#[[it07:Angelic Acid|Angelic Acid]]&lt;br /&gt;
#[[it07:Melem (Melon) |Melem]]&lt;br /&gt;
#[[it07:oxazaborolidines|Chiral Oxazaborolidines as Catalysts]]&lt;br /&gt;
#[[it07:RDX|RDX (chemical in plastic explosives)]]&lt;br /&gt;
#[[it07:Lysergic Acid|Lysergic Acid]]&lt;br /&gt;
#[[it07:Oseltamivir Phosphate|Oseltamivir Phosphate(Tamiflu)]]&lt;br /&gt;
#[[Fluoxetine Hydrochloride (Prozac)]]&lt;br /&gt;
#[[Dimethylmercury]]&lt;br /&gt;
#[[it07:Sorafenib(Nexavar®)|Sorafenib (Nexavar®)]]&lt;br /&gt;
#[[Rapamycin]]&lt;br /&gt;
#[[Rohypnol]]&lt;br /&gt;
#[[it07:Vitamin A|Vitamin A (Retinol)]]&lt;br /&gt;
#[[it07:THC|Tetrahydrocannabinol]]&lt;br /&gt;
#[[2,4-Dinitrophenylhydrazine|2,4-Dinitrophenylhydrazine]]&lt;br /&gt;
#[[Acetylcholine]]&lt;br /&gt;
#[[it07:Phenolphthalein|Phenolphthalein]]&lt;br /&gt;
#[[Carbon Dioxide]]&lt;br /&gt;
#[[Domoic Acid]]&lt;br /&gt;
#[[Kevlar]]&lt;br /&gt;
#[[it07:Erythromycin|Erythromycin]]&lt;br /&gt;
#[[it07:DIBAL|DIBAL]]&lt;br /&gt;
#[[Ephedrine]]&lt;br /&gt;
#[[it07:Lactose|Lactose]]&lt;br /&gt;
#[[it07:Thyjone|Thyjone]]&lt;br /&gt;
#[[Levothyroxine]]&lt;br /&gt;
#[[it07:Tropinone|Tropinone]]&lt;br /&gt;
#[[it07:Ozone|Ozone]]&lt;br /&gt;
#[[it07:Indinavir|Indinavir (Crixivan®)]]&lt;br /&gt;
#[[it07:Tetrodotoxin|Tetrodotoxin]]&lt;br /&gt;
#[[it07:Astaxanthin|Astaxanthin]]&lt;br /&gt;
#[[Methane]]&lt;br /&gt;
#[[it07:2 – Chlorobenzalmalononitrile|2 – Chlorobenzalmalononitrile (CS Gas)]]&lt;br /&gt;
#[[it07:Dichloro-Diphenyl-Trichloroethane|Dichloro-Diphenyl-Trichloroethane]]&lt;br /&gt;
#[[it07:Ketamine|Ketamine]]&lt;br /&gt;
#[[it07:Ethylene Glycol|Ethylene Glycol]]&lt;br /&gt;
#[[it07:HMX|HMX]]&lt;br /&gt;
#[[it07:Psilocybin|Psilocybin (magic mushrooms)]]&lt;br /&gt;
#[[it07:Dopamine|Dopamine]]&lt;br /&gt;
#[[it07:Mefenamic Acid|Mefenamic Acid]]&lt;br /&gt;
#[[it07:Sesamin|Sesamin]]&lt;br /&gt;
#[[it07:Riboflavin|Riboflavin (Vitamin B2)]]&lt;br /&gt;
#[[it07:Coniine|Coniine]]&lt;br /&gt;
#[[it07:Capecitabine|Capecitabine]]&lt;br /&gt;
#[[it07:Atenolol|Atenolol]]&lt;br /&gt;
&lt;br /&gt;
== Wiki Templates ==&lt;br /&gt;
&lt;br /&gt;
[[Template:DOI]] and [[Template:Doi-inline]] are providea as (protected) templates for your use. Many other templates exist, often to be found on e.g. Wikipedia pages. You may decide one of these is of particular use, or of interest. If so, you can install it on the wiki here for you and others to use. Add below a line that looks like Template:Template-name, save, and click on the red text to create the new template. If you prefer the task of adding useful templates to that of adding information about molecules, then you will be given full credit for performing this valuable service for others! --Rzepa 14:41, 20 October 2006 (BST) &lt;br /&gt;
&lt;br /&gt;
[[Template:Chem-Data]]&lt;br /&gt;
&lt;br /&gt;
[[Template:Drug-Box]] - For pharmaceutical drugs just copy variable names and code generates tables&lt;br /&gt;
&lt;br /&gt;
[[Template:Chembox supplement]] - to be linked to from the supplementary section of the table in the template above, for usage see [[Template_talk:chembox_supplement|here]]&lt;br /&gt;
&lt;br /&gt;
[[Template:NFPA_704]] - for notes on how to use, see [[Template_talk:NFPA_704|here]]&lt;br /&gt;
&lt;br /&gt;
[[R &amp;amp; S Phrases]]&lt;br /&gt;
&lt;br /&gt;
[[Template:Chembox new]]&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin_mass_spec.GIF&amp;diff=13683</id>
		<title>File:Simvastatin mass spec.GIF</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin_mass_spec.GIF&amp;diff=13683"/>
		<updated>2007-12-06T22:02:12Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin_nmr.GIF&amp;diff=13681</id>
		<title>File:Simvastatin nmr.GIF</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin_nmr.GIF&amp;diff=13681"/>
		<updated>2007-12-06T21:41:22Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin.gif&amp;diff=13673</id>
		<title>File:Simvastatin.gif</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin.gif&amp;diff=13673"/>
		<updated>2007-12-06T21:04:14Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol_mass_spec.GIF&amp;diff=13660</id>
		<title>File:Atenolol mass spec.GIF</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol_mass_spec.GIF&amp;diff=13660"/>
		<updated>2007-12-06T20:01:40Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol_IR.GIF&amp;diff=13659</id>
		<title>File:Atenolol IR.GIF</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol_IR.GIF&amp;diff=13659"/>
		<updated>2007-12-06T20:01:20Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Vit.MOL&amp;diff=13377</id>
		<title>File:Vit.MOL</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Vit.MOL&amp;diff=13377"/>
		<updated>2007-12-06T11:03:53Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin_synthesis.gif&amp;diff=13376</id>
		<title>File:Simvastatin synthesis.gif</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin_synthesis.gif&amp;diff=13376"/>
		<updated>2007-12-06T10:42:59Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Sim.PDB&amp;diff=13350</id>
		<title>File:Sim.PDB</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Sim.PDB&amp;diff=13350"/>
		<updated>2007-12-05T20:04:09Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin.PDB&amp;diff=13349</id>
		<title>File:Simvastatin.PDB</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin.PDB&amp;diff=13349"/>
		<updated>2007-12-05T19:59:22Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin.MOL&amp;diff=13346</id>
		<title>File:Simvastatin.MOL</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Simvastatin.MOL&amp;diff=13346"/>
		<updated>2007-12-05T19:52:25Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol.MOL&amp;diff=13324</id>
		<title>File:Atenolol.MOL</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol.MOL&amp;diff=13324"/>
		<updated>2007-12-05T19:06:21Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol_synthesis.gif&amp;diff=13323</id>
		<title>File:Atenolol synthesis.gif</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol_synthesis.gif&amp;diff=13323"/>
		<updated>2007-12-05T19:04:37Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol.gif&amp;diff=13316</id>
		<title>File:Atenolol.gif</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol.gif&amp;diff=13316"/>
		<updated>2007-12-05T18:43:27Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol.GIF&amp;diff=13315</id>
		<title>File:Atenolol.GIF</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=File:Atenolol.GIF&amp;diff=13315"/>
		<updated>2007-12-05T18:39:22Z</updated>

		<summary type="html">&lt;p&gt;Hm206: diagram of atenolol molecular structure&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;diagram of atenolol molecular structure&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
	<entry>
		<id>https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Bufotoxin&amp;diff=10417</id>
		<title>It07:Bufotoxin</title>
		<link rel="alternate" type="text/html" href="https://chemwiki.ch.ic.ac.uk/index.php?title=It07:Bufotoxin&amp;diff=10417"/>
		<updated>2007-10-31T14:50:40Z</updated>

		<summary type="html">&lt;p&gt;Hm206: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=Bufotoxin=&lt;br /&gt;
&lt;br /&gt;
Bufotoxin is a composition of toxins that are used by some toads (genus Bufo). It can be found on the skin of the toads as well as in the venom and the parotoid glands. The toxin consists of a mixture of:&lt;br /&gt;
&lt;br /&gt;
5-MeO-DMT, bufagins, bufotalin, bufotenine, bufothionine, [http://www.ch.imperial.ac.uk/wiki/index.php/It07:Epinephrine epinephrine], norepinephrine, and serotonin.&lt;br /&gt;
&lt;br /&gt;
The composition of the toxin depends where exactly the toxin comes from. Some plants mushrooms and amphibians also use the toxin. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Bufotenin (&#039;&#039;also&#039;&#039; Bufotenine)==&lt;br /&gt;
&lt;br /&gt;
Bufotenin (a typtamine alkaloid)is used by some animals for there hallucinogenic ability in a defence system. It is found in mushrooms, some plants, mammals and possibly in bodily fluids of schizophrenics.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;General Information&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Systematic name: 3-(2-Dimethylamino-ethyl)-1&#039;&#039;H&#039;&#039;-indol-5-ol&lt;br /&gt;
&lt;br /&gt;
Molecular Formula: C&amp;lt;sub&amp;gt;12&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;16&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&lt;br /&gt;
&lt;br /&gt;
Molecular weight: 204.27 g/mol&lt;br /&gt;
&lt;br /&gt;
Melting point: 146.5 °C  &amp;lt;ref&amp;gt;I. J. Pachter, D. E. Zacharias and O. Ribeiro, J. Org. Chem., 1959, 24, 1285-1287.{{DOI|10.1021/jo01091a032}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Smile: OC1=CC2=C(NC=C2CCN(C)C)C=C1&lt;br /&gt;
&lt;br /&gt;
[[Image: bufotenin.gif|thumb|right|200|Bufotenin 2D image]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===3D representation of &#039;&#039;Bufotenin molecule&#039;&#039;===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
&amp;lt;size&amp;gt;250&amp;lt;/size&amp;gt;&lt;br /&gt;
&amp;lt;color&amp;gt;white&amp;lt;/color&amp;gt;&lt;br /&gt;
&amp;lt;script&amp;gt;zoom 80; cpk on;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1&amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;inlineContents&amp;gt;Bufotoxin&lt;br /&gt;
  DSViewer          3D                             0&lt;br /&gt;
&lt;br /&gt;
 15 16  0  0  0  0  0  0  0  0999 V2000&lt;br /&gt;
    1.4600   -1.5600    0.0000 C   0  0  0  0  0  0  0  0  0  1&lt;br /&gt;
    2.4600   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  2&lt;br /&gt;
    0.4700   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  3&lt;br /&gt;
    3.4600   -1.5600    0.0000 N   0  0  0  0  0  0  0  0  0  4&lt;br /&gt;
   -1.5200   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  5&lt;br /&gt;
    0.4700    0.8500    0.0000 C   0  0  0  0  0  0  0  0  0  6&lt;br /&gt;
    4.4600   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  7&lt;br /&gt;
    3.4600   -3.1700    0.0000 C   0  0  0  0  0  0  0  0  0  8&lt;br /&gt;
   -1.5200    0.8500    0.0000 C   0  0  0  0  0  0  0  0  0  9&lt;br /&gt;
   -2.5100   -1.5600    0.0000 C   0  0  0  0  0  0  0  0  0 10&lt;br /&gt;
   -0.5200    1.6600    0.0000 N   0  0  0  0  0  0  0  0  0 11&lt;br /&gt;
   -2.5100    1.6600    0.0000 C   0  0  0  0  0  0  0  0  0 12&lt;br /&gt;
   -3.5100   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0 13&lt;br /&gt;
   -3.5100    0.8500    0.0000 C   0  0  0  0  0  0  0  0  0 14&lt;br /&gt;
   -4.5100   -1.5600    0.0000 O   0  0  0  0  0  0  0  0  0 15&lt;br /&gt;
  1  2  1  0  0  0&lt;br /&gt;
  1  3  1  0  0  0&lt;br /&gt;
  2  4  1  0  0  0&lt;br /&gt;
  3  5  1  0  0  0&lt;br /&gt;
  3  6  2  0  0  0&lt;br /&gt;
  4  7  1  0  0  0&lt;br /&gt;
  4  8  1  0  0  0&lt;br /&gt;
  5  9  2  0  0  0&lt;br /&gt;
  5 10  1  0  0  0&lt;br /&gt;
  6 11  1  0  0  0&lt;br /&gt;
  9 11  1  0  0  0&lt;br /&gt;
  9 12  1  0  0  0&lt;br /&gt;
 10 13  2  0  0  0&lt;br /&gt;
 12 14  2  0  0  0&lt;br /&gt;
 13 14  1  0  0  0&lt;br /&gt;
 13 15  1  0  0  0&lt;br /&gt;
M  END&amp;lt;/inlineContents&amp;gt;&lt;br /&gt;
&amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===3D model of Bufotenin unit cell===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;Pentahelicene&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;300&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;BUFTEN.cif&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;Infrared spectrum&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
IR peaks (Nujol): 3620 cm&amp;lt;sup&amp;gt;-1&amp;lt;/sup&amp;gt; [http://pubs.acs.org/cgi-bin/article.cgi/joceah/2002/67/i07/html/jo0110597.html journal] &amp;lt;ref&amp;gt;G. Revial, I. Jabin, S. Lim and M. Pfau, J. Org. Chem., 2002, 67, 2252-2256.{{DOI|10.1021/jo0110597}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;NMR&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt;H NMR&#039;&#039; peaks (D&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O): adapted from [http://pubs.acs.org/cgi-bin/article.cgi/joceah/2002/67/i07/html/jo0110597.html journal]&amp;lt;ref&amp;gt;G. Revial, I. Jabin, S. Lim and M. Pfau, J. Org. Chem., 2002, 67, 2252-2256.{{DOI|10.1021/jo0110597}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
{| border=&amp;quot;3&amp;quot;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
! Chemical shift&lt;br /&gt;
&lt;br /&gt;
! Splitting multiplicity&lt;br /&gt;
&lt;br /&gt;
! Integration&lt;br /&gt;
&lt;br /&gt;
! Coupling constant (J/Hz)&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| 2.76&lt;br /&gt;
&lt;br /&gt;
| singlet&lt;br /&gt;
&lt;br /&gt;
| 6H&lt;br /&gt;
&lt;br /&gt;
| N\A&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| 2.95&lt;br /&gt;
&lt;br /&gt;
| triplet&lt;br /&gt;
&lt;br /&gt;
| 2H&lt;br /&gt;
&lt;br /&gt;
| 7.5&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| 3.18&lt;br /&gt;
&lt;br /&gt;
| triplet&lt;br /&gt;
&lt;br /&gt;
| 2H&lt;br /&gt;
&lt;br /&gt;
| 7.5&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| 6.86&lt;br /&gt;
&lt;br /&gt;
| double doublet&lt;br /&gt;
&lt;br /&gt;
| 1H&lt;br /&gt;
&lt;br /&gt;
| 8.8, 2.6&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| 7.02&lt;br /&gt;
&lt;br /&gt;
| doublet&lt;br /&gt;
&lt;br /&gt;
| 1H&lt;br /&gt;
&lt;br /&gt;
| 2.6&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| 7.15&lt;br /&gt;
&lt;br /&gt;
| singlet&lt;br /&gt;
&lt;br /&gt;
| 1H&lt;br /&gt;
&lt;br /&gt;
| N\A&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| 7.38&lt;br /&gt;
&lt;br /&gt;
| doublet&lt;br /&gt;
&lt;br /&gt;
| 1H&lt;br /&gt;
&lt;br /&gt;
| 8.8&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;Mass Spectrum&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
[[Image:Bufomass.JPG|thumb|left|Mass spectrum of Bufotenin&amp;lt;ref&amp;gt;T. O. G. Costa, R. A. V. Morales, J. P. Brito, M. Gordo, A. C. Pinto and J. C. Bloch, Toxicon, 2005, 46, 371-375.&lt;br /&gt;
{{DOI|10.1016/j.toxicon.2005.02.006}}&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
==Human experience of Bufotenin vapour ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt;Erowid experience vaults:http://www.erowid.org/experiences/exp.php?ID=64707&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After inhaling the fumes from the bufotenin the inital effect is an increased intensity of visuals and and anxiety accompanied by a general increased awareness. The next step in the experience is hallucinating and seeing swirling around the room with sweating. After a while the sweating and anxiety stops and a more relexed atmosphere still with strong hallucinating effects occurs. After a couple of hours the effect wears off into nothing. The effect of the bufotenin can depend on which form the bufotenin is in e.g. calcium bufotenin or bufotenin hydrochloride can have very different effects.&lt;br /&gt;
&lt;br /&gt;
==Serotonin==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;General Information&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
IUPAC Name: 3-(2-aminoethyl)-1H-indol-5-ol&lt;br /&gt;
&lt;br /&gt;
Molecular Formula: C&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;12&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&lt;br /&gt;
&lt;br /&gt;
Molecular weight: 176.215 g/mol&lt;br /&gt;
&lt;br /&gt;
Smile: OC1=CC=C(NC=C2CCN)C2=C1&lt;br /&gt;
&lt;br /&gt;
PubChem: 5202 &lt;br /&gt;
&lt;br /&gt;
[[Image:Serotonin.jpg|thumb|right|200|Serotonin Structure]]&lt;br /&gt;
&lt;br /&gt;
3D Representation of &#039;&#039;Serotonin&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;Serotonin&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;Black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;200&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Serotonin3d.pdb&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Serotonin picrate monohydrate &#039;&#039;Crystal Unit Cell&#039;&#039; (C&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;13&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;,  C&amp;lt;sub&amp;gt;6&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;7&amp;lt;/sub&amp;gt;&amp;lt;sup&amp;gt;-&amp;lt;/sup&amp;gt;,  H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
  &amp;lt;jmolApplet&amp;gt;&lt;br /&gt;
     &amp;lt;title&amp;gt;Serotonin&amp;lt;/title&amp;gt;&amp;lt;color&amp;gt;Black&amp;lt;/color&amp;gt;&lt;br /&gt;
     &amp;lt;size&amp;gt;200&amp;lt;/size&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;zoom 80; cpk -25;frame 1; move 10 -20 10 0 0 0 0 0 3; delay 1;&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;uploadedFileContents&amp;gt;Serotoninunit.cif&amp;lt;/uploadedFileContents&amp;gt;&lt;br /&gt;
  &amp;lt;/jmolApplet&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
 &lt;br /&gt;
    &amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Start spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin on&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Stop spinning&amp;lt;/text&amp;gt;&amp;lt;script&amp;gt;spin off&amp;lt;/script&amp;gt;&amp;lt;/item&amp;gt;&lt;br /&gt;
     &amp;lt;menuHeight&amp;gt;-1&amp;lt;/menuHeight&amp;gt;&lt;br /&gt;
   &amp;lt;/jmolMenu&amp;gt;&lt;br /&gt;
   &amp;lt;jmolButton&amp;gt;&lt;br /&gt;
     &amp;lt;script&amp;gt;console&amp;lt;/script&amp;gt;&lt;br /&gt;
     &amp;lt;text&amp;gt;open a console window&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=References=&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Hm206</name></author>
	</entry>
</feed>